Trastuzumab Completed Phase 1 Trials for Malignancies Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00005842Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer